Researchers improve CRISPR-Cas9 delivery efficiency
A team has used a lentiviral capsid-based bionanoparticle system to deliver CRISPR-Cas9 gene editing therapies, reducing undesired effects.
List view / Grid view
A team has used a lentiviral capsid-based bionanoparticle system to deliver CRISPR-Cas9 gene editing therapies, reducing undesired effects.
New research findings suggest that gut microbiota may regulate lupus flares in pregnant women, presenting a therapeutic target.
A new drug discovery strategy predicts the clinical actions of new compounds to promote desired clinical responses and avoid side effects.
Scientists have discovered a molecular pathway that contributes to PAH development, which may lead to a new drug target for the disease.
Researchers have discovered that B cells aid T cells in fighting cancer, which could be an area of development for immunotherapies.
A potential treatment for polycystic kidney disease has shown positive results in animal testing.
The UK Biobank, the world’s largest genetics project, will sequence 500,000 genetic samples, which will be available to researchers everywhere.
Researchers have discovered an enzyme that is pivotal in deciding whether cells survive or die in inflammatory diseases, so provides a drug target.
Researchers have developed a new treatment method which turned glial cells into functioning neurons in mice after stroke.
A ground-breaking nervous system discovery could be significant for the treatment of different neurological diseases.
Using both computational models and stem cell-based experiments, researchers have identified a gene regulator of schizophrenia.
New study finds immunotherapy reduces cardiac fibrosis and restores heart function in mice after cardiac injury.
A study on how Polycombs regulate cellular identity could lead to alternative treatments for patients with drug-resistant cancer.
A research team have identified a protein that binds breast cancer cells together, allowing them to metastasise, which could be significant in the development of cancer therapies.
A clinical study comparing liquid and tissue biopsies finds multiple resistance mechanisms in individual patients.